Ratings by Needham & Company (Gil Blum)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/5/2021 Taysha Gene Therapies TSHA Maintain Buy
(N/A)
 
 
  Details
7/16/2021 Taysha Gene Therapies TSHA New Coverage Buy
(N/A)
20.50
(16.24)
-20.78% Details
5/27/2021 Amicus Therapeutics FOLD New Coverage Hold
(N/A)
9.00
(10.73)
19.22% Details
5/27/2021 Avrobio Inc. AVRO New Coverage Buy
(N/A)
8.05
(5.50)
-31.68% Details
2/18/2021 Rocket Pharmaceuticals RCKT New Coverage Buy
(N/A)
52.62
(29.75)
-43.46% Details
2/18/2021 Generation Bio GBIO New Coverage Buy
(N/A)
31.79
(22.02)
-30.73% Details